These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36861117)

  • 1. Comorbid conditions as predictors of mortality in severe COPD - an eight-year follow-up cohort study.
    Eliasson G; Janson C; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Sundh J
    Eur Clin Respir J; 2023; 10(1):2181291. PubMed ID: 36861117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality - A 15-Year Follow-Up.
    Giezeman M; Sundh J; Athlin Å; Lisspers K; Ställberg B; Janson C; Montgomery S; Kisiel MA; Nager A; Sandelowsky H; Hasselgren M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():11-21. PubMed ID: 36644219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death - A National Register Study.
    Henoch I; Ekberg-Jansson A; Löfdahl CG; Strang P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1495-1505. PubMed ID: 32612357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD.
    Budweiser S; Harlacher M; Pfeifer M; Jörres RA
    COPD; 2014 Aug; 11(4):388-400. PubMed ID: 24111878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEV
    Bikov A; Lange P; Anderson JA; Brook RD; Calverley PMA; Celli BR; Cowans NJ; Crim C; Dixon IJ; Martinez FJ; Newby DE; Yates JC; Vestbo J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1135-1142. PubMed ID: 32547001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.
    Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
    Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
    Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy.
    Marti S; Muñoz X; Rios J; Morell F; Ferrer J
    Eur Respir J; 2006 Apr; 27(4):689-96. PubMed ID: 16585077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
    Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
    Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
    Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - a case finding study.
    Sandelowsky H; Ställberg B; Nager A; Hasselström J
    BMC Fam Pract; 2011 Nov; 12():122. PubMed ID: 22047519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia.
    Nizet TA; van den Elshout FJ; Heijdra YF; van de Ven MJ; Mulder PG; Folgering HT
    Chest; 2005 Jun; 127(6):1904-10. PubMed ID: 15947301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries.
    Gudmundsson G; Ulrik CS; Gislason T; Lindberg E; Brøndum E; Bakke P; Janson C
    Int J Chron Obstruct Pulmon Dis; 2012; 7():571-6. PubMed ID: 23055707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight is a predictor of long-term survival in hospitalised patients with exacerbations of COPD.
    Stoll P; Foerster S; Virchow JC; Lommatzsch M
    Respir Med; 2016 Jul; 116():59-62. PubMed ID: 27296822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
    Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting frequent COPD exacerbations using primary care data.
    Kerkhof M; Freeman D; Jones R; Chisholm A; Price DB;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2439-50. PubMed ID: 26609229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Ezponda A; Casanova C; Cabrera C; Martin-Palmero Á; Marin-Oto M; Marín JM; Pinto-Plata V; Divo M; Celli BR; Zulueta JJ; Bastarrika G; de-Torres JP
    Arch Bronconeumol; 2021 Aug; 57(8):533-539. PubMed ID: 35699031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Vertebral Bone Density Seen on Chest CT in Chronic Obstructive Pulmonary Disease Patients: Association with Mortality in the Korean Obstructive Lung Disease Cohort.
    Hwang HJ; Lee SM; Seo JB; Kim JE; Choi HY; Kim N; Lee JS; Lee SW; Oh YM
    Korean J Radiol; 2020 Jul; 21(7):880-890. PubMed ID: 32524788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.